ALZHEIMER'S
DEMENTIA CASE
study
Al Stein, MD
Plantation, Florida
My most outstanding result with
5-HTP, tyrosine,
levodopa, and cysteine therapy has
occurred in 87 year-old person who was seen on March
31, 2006. A very recent psychological evaluation for
cognitive functioning included a mini mental state
examination (MMSE), clinical interview, and mental
status evaluation. The person scored 15 out of a
possible 30 on the MMSE. She was unable to interact, or
converse in a logical or coherent manner, and her
responses were frequently illogical and inappropriate to
the questions.
The psychologist concluded that the person was
suffering major cognitive dysfunction and senile
dementia. An individual with this level of impairment
would be unable to function independently. The family
sought an Alzheimer facility for custodial care.
She was started on level 1
5-HTP, tyrosine,
levodopa, and cysteine dosing. One week
later there was not much change. We increased her to
level 2
5-HTP, tyrosine,
levodopa, and cysteine dosing.
On May 2, 2006 she returned to the office alert,
making sense. She was able to hold a conversation, knew
her birthday, was smiling, talkative, and happy. Her
family was amazed.
She had had an episode of several days of severely
foul-smelling stools for what seemed to be no specific
reason. This was probably her body discharging
petrochemicals and aromatic hydrocarbons that had been
stored in her body and were making her toxic. The
cysteine/selenium formula developed by Dr. Hinz no doubt
helped her liver clear these items through the
intestinal tract.
The family elected to keep the person at home.
The person currently lives in her own apartment with a
companion. She likes to get dressed in bright colored
clothes, enjoys going out to the malls, visiting with
other people. She has returned to the world of the
cognizant, social people while continuing to take the
5-HTP, tyrosine,
levodopa, and cysteine treatment program. She is doing very well
now in her 88th year and is very happy.
|
